PD‐L1 in oral squamous cell carcinoma: A key biomarker from the laboratory to the bedside

Objectives and background: Oral squamous cell carcinoma (OSCC) is a highly malignant disease with an increasing incidence. The need to improve therapeutic strategies for patients affected by OSCC is an urgent challenge. Currently, the advent of immunotherapy represents an important step toward this...

Descripción completa

Detalles Bibliográficos
Autores principales: Nocini, Riccardo, Vianini, Matteo, Girolami, Ilaria, Calabrese, Luca, Scarpa, Aldo, Martini, Maurizio, Morbini, Patrizia, Marletta, Stefano, Brunelli, Matteo, Molteni, Gabriele, Parwani, Anil, Pantanowitz, Liron, Eccher, Albino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209791/
https://www.ncbi.nlm.nih.gov/pubmed/35593124
http://dx.doi.org/10.1002/cre2.590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209791/
https://www.ncbi.nlm.nih.gov/pubmed/35593124
http://dx.doi.org/10.1002/cre2.590

Ejemplares similares